GO:0008147 structural constituent of bone: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008147 (structural constituent of bone) is a molecular function describing the action of a molecule that contributes to the structural integrity of bone.
• Type I collagen is the principal organic structural protein of bone, providing a scaffold for mineral deposition and contributing to tensile strength.
• Bone structural integrity depends on the hierarchical assembly of collagen fibrils with hydroxyapatite crystals, a process regulated by phosphate and other ions.
• Non-collagenous proteins such as osteocalcin, osteopontin, and bone sialoprotein also contribute to bone structure and mineralization.
• Dentin and bone share structural proteins, and dentinogenesis provides insights into biomineralization mechanisms relevant to GO:0008147.
• Mechanical loading influences cancellous bone structural adaptation, linking physical forces to the molecular function of bone structural constituents.
Description
GO:0008147, structural constituent of bone, is a molecular function term in the Gene Ontology that describes the action of a molecule contributing to the structural integrity of bone. This function is essential for understanding how bone tissue maintains its mechanical competence and resilience. Bone is a composite material consisting of an organic matrix, primarily type I collagen, and an inorganic mineral phase, hydroxyapatite. The structural constituents of bone are responsible for the tissue's ability to withstand mechanical loads and protect vital organs. Research into this GO term is critical for elucidating the molecular basis of bone strength, the pathophysiology of skeletal diseases, and the development of biomimetic materials. The structural integrity of bone relies on the precise assembly of collagen fibrils and their subsequent mineralization, processes that are tightly regulated by a variety of proteins and ions. Disruptions in these components can lead to bone fragility, as seen in osteogenesis imperfecta and other skeletal disorders. Therefore, studying GO:0008147 provides a framework for understanding bone biology at the molecular level and for identifying therapeutic targets.
structural constituent of bone At A Glance
| GO ID | GO:0008147 |
|---|---|
| GO term | structural constituent of bone |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Contributes to the structural integrity of bone |
| Major proteins | Type I collagen, osteocalcin, osteopontin, bone sialoprotein |
| Related process | Bone mineralization, bone remodeling |
| Disease relevance | Osteogenesis imperfecta, osteoporosis, fractures |
What Is GO:0008147?
The Gene Ontology defines GO:0008147 as the action of a molecule that contributes to the structural integrity of bone. This molecular function encompasses proteins that form the structural framework of bone tissue, such as collagen and non-collagenous matrix proteins, which provide mechanical support and a template for mineralization.
Why Is structural constituent of bone Important in Cell Biology?
Understanding GO:0008147 is fundamental to bone biology because it defines the molecular components that give bone its unique mechanical properties. These structural constituents are not merely passive scaffolds; they actively participate in mineralization, cell signaling, and adaptation to mechanical load. Dysregulation of these proteins leads to skeletal diseases characterized by bone fragility, making them key targets for therapeutic intervention and tissue engineering.
• Provides the molecular basis for bone mechanical strength and fracture resistance.
• Essential for biomineralization, as collagen fibrils template hydroxyapatite deposition.
• Mutations in structural proteins cause osteogenesis imperfecta and other skeletal dysplasias.
• Involved in bone remodeling, a process critical for calcium homeostasis and skeletal maintenance.
• Mechanical loading modulates the expression and organization of bone structural constituents.
• Serves as a target for biomimetic scaffolds in regenerative medicine.
• Contributes to the understanding of dentinogenesis due to shared proteins with bone.
• Relevant to intervertebral disc degeneration, where structural integrity of adjacent bone is affected.
• Key for developing treatments for osteoporosis and age-related bone loss.
• Enables the design of novel materials inspired by bone's hierarchical structure.
Molecular Mechanism of structural constituent of bone
Collagen Synthesis and Fibrillogenesis
In simple terms: Collagen is made inside cells and then assembled outside into strong fibers.
Type I collagen is synthesized as procollagen, which undergoes post-translational modifications and is secreted into the extracellular space. There, procollagen is cleaved to tropocollagen, which self-assembles into fibrils. These fibrils provide the organic framework for bone and are essential for its tensile strength.
Mineralization and Hydroxyapatite Deposition
In simple terms: Minerals are deposited onto the collagen fibers, making bone hard.
Collagen fibrils serve as a template for the nucleation and growth of hydroxyapatite crystals. This process is regulated by phosphate ions and non-collagenous proteins such as osteocalcin and bone sialoprotein, which control crystal size and orientation.
Non-collagenous Proteins and Matrix Organization
In simple terms: Other proteins help organize the bone matrix and control mineralization.
Proteins like osteopontin, osteocalcin, and bone sialoprotein are incorporated into the bone matrix. They modulate collagen fibril assembly, regulate mineral deposition, and contribute to cell-matrix interactions. Their precise spatiotemporal expression is critical for bone structural integrity.
Mechanical Adaptation and Remodeling
In simple terms: Bone changes its structure in response to physical forces.
Mechanical loading influences the orientation and density of collagen fibers and mineral crystals in cancellous bone. Osteocytes sense mechanical signals and regulate bone remodeling, ensuring that the structural constituents are organized to withstand habitual loads.
Fracture Resistance Mechanisms
In simple terms: Bone has special features that stop cracks from spreading.
The hierarchical structure of bone, including nanofibril-mediated mechanisms, provides fracture resistance. Collagen fibrils and their interfaces with mineral crystals dissipate energy and deflect cracks, preventing catastrophic failure.
Key Genes Involved in GO:0008147 structural constituent of bone
The following genes encode proteins that function as structural constituents of bone or regulate their assembly and mineralization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Encodes alpha-1 chain of type I collagen | Mutations cause osteogenesis imperfecta; target for bone regeneration |
| COL1A2 | Encodes alpha-2 chain of type I collagen | Mutations cause osteogenesis imperfecta; collagen fibril assembly |
| BGLAP | Encodes osteocalcin, a non-collagenous bone protein | Marker of bone formation; regulates mineralization |
| SPP1 | Encodes osteopontin, a matrix protein | Involved in bone remodeling and mineralization |
| IBSP | Encodes bone sialoprotein | Nucleates hydroxyapatite; cell attachment |
| DMP1 | Encodes dentin matrix protein 1 | Regulates mineralization in bone and dentin |
| MEPE | Encodes matrix extracellular phosphoglycoprotein | Involved in phosphate metabolism and mineralization |
| PHOSPHO1 | Phosphatase involved in mineralization | Generates phosphate for hydroxyapatite formation |
| ALPL | Tissue-nonspecific alkaline phosphatase | Provides phosphate for mineralization; mutations cause hypophosphatasia |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | Regulates pyrophosphate levels, affecting mineralization |
| ANKH | Progressive ankylosis protein | Transports pyrophosphate; mutations cause craniometaphyseal dysplasia |
| RUNX2 | Master transcription factor for osteoblast differentiation | Regulates expression of bone matrix genes |
| SP7 | Osterix, transcription factor for osteoblast differentiation | Essential for bone formation |
| SOX9 | Transcription factor for chondrogenesis | Indirectly affects bone formation via endochondral ossification |
| MMP13 | Matrix metalloproteinase 13 | Degrades collagen during bone remodeling |
| CTSK | Cathepsin K | Collagenase involved in bone resorption |
| TGFB1 | Transforming growth factor beta 1 | Regulates collagen synthesis and bone remodeling |
How Is structural constituent of bone Regulated?
The expression and activity of bone structural constituents are regulated at multiple levels. Transcription factors such as RUNX2 and SP7 control the differentiation of osteoblasts and the expression of bone matrix genes. Mechanical loading modulates gene expression through mechanotransduction pathways involving osteocytes. Hormones including parathyroid hormone and vitamin D regulate calcium and phosphate homeostasis, influencing mineralization. Post-translational modifications of collagen, such as hydroxylation and cross-linking, are essential for fibril stability and are regulated by specific enzymes.
structural constituent of bone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| COL1A1 | Osteogenesis imperfecta | Knock-in mouse with Gly substitution; patient-derived iPSCs |
| COL1A2 | Osteogenesis imperfecta | Knockout or knock-in in zebrafish; osteoblast cultures |
| ALPL | Hypophosphatasia | Knockout mouse; induced pluripotent stem cells |
| ENPP1 | Generalized arterial calcification of infancy | Knockout mouse; cell-based mineralization assays |
| SPP1 | Osteopontin deficiency and bone remodeling | Knockout mouse; bone marrow stromal cell cultures |
Osteogenesis Imperfecta
Osteogenesis imperfecta is a genetic disorder characterized by bone fragility, primarily caused by mutations in COL1A1 or COL1A2, which encode type I collagen. These mutations disrupt collagen fibril formation, leading to reduced bone structural integrity and increased fracture risk.
Osteoporosis
Osteoporosis is characterized by low bone mass and deterioration of bone microarchitecture, resulting from an imbalance in bone remodeling. Alterations in the synthesis and organization of structural constituents, such as collagen and non-collagenous proteins, contribute to bone fragility.
Hypophosphatasia and Mineralization Disorders
Hypophosphatasia is caused by mutations in ALPL, leading to defective mineralization. Other disorders of phosphate metabolism, such as those involving ENPP1 or ANKH, also affect hydroxyapatite deposition and bone structural integrity.
Intervertebral Disc Degeneration
Degeneration of the intervertebral disc is associated with changes in the adjacent vertebral bone, including alterations in collagen and mineral content. The structural constituents of bone play a role in the pathophysiology of disc degeneration and associated back pain.
From structural constituent of bone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does COL1A1 mutation affect collagen fibril structure? | Knock-in mouse expressing mutant collagen |
| What is the role of osteocalcin in mineralization? | BGLAP knockout mouse |
| How does mechanical loading regulate bone structural genes? | In vivo loading models in mice; osteocyte-specific knockout |
| Can CRISPR correct osteogenesis imperfecta mutations? | Patient iPSCs with point mutation correction |
| What is the effect of ALPL overexpression on mineralization? | Transgenic mouse overexpressing ALPL |
| How do non-collagenous proteins interact with collagen? | In vitro binding assays with recombinant proteins |
How to Study the structural constituent of bone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Von Kossa staining | Mineralized matrix | Assessment of bone formation in tissue sections |
| Immunohistochemistry | Protein localization | Detection of collagen and non-collagenous proteins |
| Transmission electron microscopy | Collagen fibril diameter and orientation | Ultrastructural analysis of bone matrix |
| Hydroxyproline assay | Collagen content | Quantification of collagen in bone samples |
| Nanoindentation | Local mechanical properties | Mapping of bone stiffness at microscale |
| Micro-CT | Bone mineral density and microarchitecture | Evaluation of bone phenotype in animal models |
| Raman spectroscopy | Mineral crystallinity and collagen maturity | Assessment of bone quality |
Histology and Immunohistochemistry
Histological techniques such as von Kossa and Alizarin Red staining visualize mineralized bone matrix, while immunohistochemistry detects specific structural proteins like type I collagen and osteocalcin in tissue sections.
Electron Microscopy
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) reveal the ultrastructure of collagen fibrils and mineral crystals, providing insights into bone hierarchical organization and fracture resistance mechanisms.
Biochemical Assays
Quantification of collagen cross-links, hydroxyproline content, and mineral content using biochemical assays allows assessment of bone matrix composition and maturation.
Mechanical Testing
Three-point bending, compression, and nanoindentation tests measure the mechanical properties of bone, linking structural constituents to whole-bone strength and fracture resistance.
How CRISPR Can Be Used to Study GO:0008147 structural constituent of bone
Knockout
CRISPR knockout of genes encoding bone structural constituents, such as COL1A1 or BGLAP, can be used to study their role in bone formation and mineralization. Knockout cell models and mice provide insights into loss-of-function phenotypes and disease mechanisms.
Point Mutation
Introducing disease-associated point mutations, such as glycine substitutions in COL1A1, using CRISPR base editing or homology-directed repair allows modeling of osteogenesis imperfecta and studying the impact on collagen structure and bone integrity.
Knock-in
Knock-in of reporter tags or human disease alleles into endogenous loci enables visualization of protein localization and dynamics in live cells, as well as creation of humanized models for drug testing.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of bone structural genes can be used to investigate the effects of increased protein levels on bone mass and mineralization, potentially identifying therapeutic targets.
How EDITGENE Supports structural constituent of bone Research
Researchers studying structural constituent of bone-related genes often need to determine whether a candidate gene is causally involved in bone formation, mineralization, or skeletal disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for structural constituent of bone research.
Frequently Asked Questions About structural constituent of bone
What is GO:0008147?
GO:0008147 is the Gene Ontology molecular function term for structural constituent of bone, describing the action of a molecule that contributes to the structural integrity of bone.
What genes are involved in structural constituent of bone?
Key genes include COL1A1, COL1A2, BGLAP, SPP1, IBSP, and ALPL, which encode collagen and non-collagenous proteins essential for bone structure and mineralization.
What is the role of type I collagen in bone?
Type I collagen is the main organic component of bone, providing a scaffold for mineral deposition and contributing to tensile strength and fracture resistance.
How is bone structural integrity maintained?
Bone structural integrity is maintained through the coordinated synthesis and assembly of collagen fibrils, regulated mineralization with hydroxyapatite, and remodeling in response to mechanical load.
What diseases are associated with defects in bone structural constituents?
Mutations in COL1A1 and COL1A2 cause osteogenesis imperfecta; ALPL mutations cause hypophosphatasia; and imbalances in remodeling lead to osteoporosis.
What research methods are used to study bone structural constituents?
Methods include histology, electron microscopy, biochemical assays, mechanical testing, and CRISPR-based gene editing to model mutations.
How does phosphate regulate bone mineralization?
Phosphate is a key substrate for hydroxyapatite formation; its levels are regulated by enzymes like ALPL and ENPP1, and disorders lead to defective mineralization.
What is the role of osteocalcin in bone?
Osteocalcin is a non-collagenous protein that regulates mineral crystal growth and is a marker of bone formation.
Can CRISPR be used to model osteogenesis imperfecta?
Yes, CRISPR can introduce disease-causing point mutations in COL1A1 or COL1A2 to create cellular and animal models of osteogenesis imperfecta.
What is the mechanical function of bone structural constituents?
They provide bone with the ability to withstand mechanical loads and resist fracture through hierarchical organization and energy dissipation mechanisms.
Conclusion
GO:0008147, structural constituent of bone, defines the molecular functions that give bone its mechanical integrity and resilience. The coordinated assembly of collagen and non-collagenous proteins with mineral crystals is essential for skeletal health, and disruptions lead to debilitating diseases such as osteogenesis imperfecta and osteoporosis. Continued research using advanced CRISPR models and imaging techniques will further elucidate these mechanisms and aid in the development of novel therapies.
References
- 1. Selvaraj V et al.. 2024. Type 1 collagen: Synthesis, structure and key functions in bone mineralization.. Differentiation 136:100757 PMID: 38437764
- 2. Raj PP. 2008. Intervertebral disc: anatomy-physiology-pathophysiology-treatment.. Pain Pract 8(1):18-44 PMID: 18211591
- 3. Bolamperti S et al.. 2022. Bone remodeling: an operational process ensuring survival and bone mechanical competence.. Bone Res 10(1):48 PMID: 35851054
- 4. Linde A et al.. 1993. Dentinogenesis.. Crit Rev Oral Biol Med 4(5):679-728 PMID: 8292714
- 5. Jacobs CR. 2000. The mechanobiology of cancellous bone structural adaptation.. J Rehabil Res Dev 37(2):209-16 PMID: 10850827
- 6. Tertuliano OA et al.. 2021. Nanofibril-mediated fracture resistance of bone.. Bioinspir Biomim 16(3) PMID: 33470971
- 7. Daood SA et al.. 2025. From an Antimicrobial Agent to a constituent of 3D Printed Heterogenous Scaffolds Stimulating Bone Characteristics: An In-vitro and Animal model evaluation.. Regen Ther 30:558-574 PMID: 40837861
- 8. Bhadada SK et al.. 2021. Role of Phosphate in Biomineralization.. Calcif Tissue Int 108(1):32-40 PMID: 32712778
